Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Mary Ann Richardson"'
Autor:
Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, Gemma Moncunill, Aina Casellas, Francisco Carmona-Torre, Miriam Giráldez, Juana Schwartz Mota, José Ramón Yuste, José Ramón Azanza, Miriam Fernández, Gabriel Reina, Carlota Dobaño, Joe Brew, Belen Sadaba, Felix Hammann, Regina Rabinovich
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-4 (2020)
Abstract Objectives The primary objective is to determine the efficacy of a single dose of ivermectin, administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom onset to reduce the proportion of patients with detectab
Externí odkaz:
https://doaj.org/article/d7c0183d2e3843dbb71c302b19ff9439
Autor:
Carlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz-Castillo, Mary-Ann Richardson, Mariano Rodríguez-Mateos, Carlota Jordán-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giráldez, Ester Laso, Juan C. Gabaldón-Figueira, Carlota Dobaño, Gemma Moncunill, José R. Yuste, Jose L. Del Pozo, N.Regina Rabinovich, Verena Schöning, Felix Hammann, Gabriel Reina, Belen Sadaba, Mirian Fernández-Alonso
Publikováno v:
EClinicalMedicine, Vol 32, Iss , Pp 100720- (2021)
Background: Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomize
Externí odkaz:
https://doaj.org/article/3566a7f25e3a4af994af0f2ba472a486
Autor:
Carlos Chaccour, Aina Casellas, Felix Hammann, Paula Ruiz-Castillo, Mary-Ann Richardson, N. Regina Rabinovich
Background: Residual malaria transmission is the result of adaptive mosquito behavior that allows malaria vectors to thrive and sustain transmission in the presence of good access to bed nets or insecticide residual spraying. These behaviors include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c2b29693e56b92edf37e8427e405c1e
https://doi.org/10.21203/rs.3.rs-2273043/v1
https://doi.org/10.21203/rs.3.rs-2273043/v1
Autor:
Belén Sádaba, Mariano Rodríguez-Mateos, Carlota Jordán-Iborra, Carlos Chaccour, Alejandro Fernández-Montero, Gabriel Reina, Andrés Blanco-Di Matteo, Felix Hammann, Jose Yuste, Mirian Fernández-Alonso, Gemma Moncunill, Iñigo Pineda, Joe Brew, Aina Casellas, Ester Laso, Verena Schöning, Paula Ruiz-Castillo, Juan C. Gabaldon-Figueira, Mary-Ann Richardson, José Luis del Pozo, Francisco Carmona-Torre, Carlota Dobaño, N. Regina Rabinovich, Miriam Giráldez
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 32, Iss, Pp 100720-(2021)
Chaccour, Carlos; Casellas, Aina; Blanco-Di Matteo, Andrés; Pineda, Iñigo; Fernandez-Montero, Alejandro; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Rodríguez-Mateos, Mariano; Jordán-Iborra, Carlota; Brew, Joe; Carmona-Torre, Francisco; Giráldez, Miriam; Laso, Ester; Gabaldón-Figueira, Juan C; Dobaño, Carlota; Moncunill, Gemma; Yuste, José R; Del Pozo, Jose L; Rabinovich, N Regina; Schöning, Verena; ... (2021). The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine, 32, p. 100720. Elsevier 10.1016/j.eclinm.2020.100720
EClinicalMedicine, Vol 32, Iss, Pp 100720-(2021)
Chaccour, Carlos; Casellas, Aina; Blanco-Di Matteo, Andrés; Pineda, Iñigo; Fernandez-Montero, Alejandro; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Rodríguez-Mateos, Mariano; Jordán-Iborra, Carlota; Brew, Joe; Carmona-Torre, Francisco; Giráldez, Miriam; Laso, Ester; Gabaldón-Figueira, Juan C; Dobaño, Carlota; Moncunill, Gemma; Yuste, José R; Del Pozo, Jose L; Rabinovich, N Regina; Schöning, Verena; ... (2021). The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine, 32, p. 100720. Elsevier 10.1016/j.eclinm.2020.100720
Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomized
Autor:
Carlos Chaccour, Aina Casellas, Andres Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz Castillo, Mary-Ann Richardson, Mariano Rodriguez Mateos, Carlota Jordan-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giraldez, Ester Laso, Carlota Dobaño, Gemma Moncunill, Jose R Yuste, Jose L Del Pozo, Regina Rabinovich, Verena Schoening, Felix Hammann, Gabriel Reina, Belen Sadaba, Miriam Fernandez-Alonso
Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomized, double-bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00ab1ec7b3d4e7737bd2e14842682434
https://doi.org/10.21203/rs.3.rs-116547/v1
https://doi.org/10.21203/rs.3.rs-116547/v1
Autor:
José Ramón Azanza, Gemma Moncunill, Belén Sádaba, Gabriel Reina, Regina Rabinovich, Carlota Dobaño, Paula Ruiz-Castillo, Mary Ann Richardson, Carlos Chaccour, Francisco Carmona-Torre, Aina Casellas, Joe Brew, Jose Yuste, Miriam Giráldez, Juana Schwartz Mota, Felix Hammann, Miriam Fernández
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-4 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Trials
Chaccour, Carlos; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Moncunill, Gemma; Casellas, Aina; Carmona-Torre, Francisco; Giráldez, Miriam; Mota, Juana Schwartz; Yuste, José Ramón; Azanza, José Ramón; Fernández, Miriam; Reina, Gabriel; Dobaño, Carlota; Brew, Joe; Sadaba, Belen; Hammann, Felix; Rabinovich, Regina (2020). The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Trials, 21(1), p. 498. BioMed Central 10.1186/s13063-020-04421-z
Dipòsit Digital de la UB
Universidad de Barcelona
Trials
Chaccour, Carlos; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Moncunill, Gemma; Casellas, Aina; Carmona-Torre, Francisco; Giráldez, Miriam; Mota, Juana Schwartz; Yuste, José Ramón; Azanza, José Ramón; Fernández, Miriam; Reina, Gabriel; Dobaño, Carlota; Brew, Joe; Sadaba, Belen; Hammann, Felix; Rabinovich, Regina (2020). The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Trials, 21(1), p. 498. BioMed Central 10.1186/s13063-020-04421-z
Objectives The primary objective is to determine the efficacy of a single dose of ivermectin, administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom onset to reduce the proportion of patients with detectable SARS-C
Publikováno v:
Group Work with Suburbia’s Children ISBN: 9781315168340
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6483e025719db65f0358130d2b488e1
https://doi.org/10.4324/9781315168340-6
https://doi.org/10.4324/9781315168340-6
Autor:
Laura L. Read, Margaret A. Reilly, Mary Ann Richardson, James D. Clelland, Catherine L. Clelland
Publikováno v:
Neurochemical Research. 32:107-113
Tetrahydrobiopterin (BH4) is an essential cofactor for amine neurotransmitter synthesis. BH4 also stimulates and modulates the glutamatergic system, and regulates the synthesis of nitric oxide by nitric oxide synthases. A connection between BH4 defic
Autor:
Jeanette, Ezzo, Mary Ann, Richardson, Andrew, Vickers, Claire, Allen, Suzanne, Dibble, Brian F, Issell, Lixing, Lao, Michael, Pearl, Gilbert, Ramirez, Joseph A, Roscoe, Joannie, Shen, Jane C, Shivnan, Konrad, Streitberger, Imad, Treish, Grant, Zhang, Eric, Manheimer
Publikováno v:
The Cochrane database of systematic reviews. (11)
Autor:
Imad Treish, Konrad Streitberger, Eric Manheimer, Claire Allen, Michael L. Pearl, Jeanette Ezzo, Mary Ann Richardson, Jane C Shivnan, Grant Zhang, Andrew J. Vickers, Joseph A. Roscoe, Gilbert Ramirez, Lixing Lao, Suzanne Dibble, Brian F. Issell, Joannie Shen
Publikováno v:
Cochrane Database of Systematic Reviews.